Rinke Sven, Reinermann Emanuel, Leha Andreas, Roediger Matthias, Ziebolz Dirk
Department of Prosthodontics, University Medical Center, Goettingen, Germany.
Department of Medical Statistics, University Medical Center, Goettingen, Germany.
J Esthet Restor Dent. 2025 Feb;37(2):561-570. doi: 10.1111/jerd.13328. Epub 2024 Oct 9.
Clinical evaluation of chairside-fabricated lithia-zirconia glass-ceramic (LZGC) partial crowns (CCPCs) in a multicenter practice-based study.
Seventy-one patients were restored with 92 adhesively luted CCPCs (Cerec SW 4.2/Cerec MC XL/Celtra Duo) in three private dental clinics (C1-C3). Time-dependent (Kaplan-Meier) survival rates (SVR) and success rates (SCR) were calculated. The following possible covariates of SVRs and SCRs were evaluated in a Cox regression model: Restoration position (premolar/molar), luting material (Variolink/Calibra), and operator (C1-C3).
Seventy-three CCPCs were placed in 59 patients and were included in the study (mean observational period: 58.0 ± 15 months). Four complete failures (two tooth fractures, one restoration fracture, and one endodontic failure) were recorded. All failures and interventions occurred in one of the three centers (5-year SCR: C1 + C2: 100%; C3: 71%; 95% confidence interval: [0.55; 0.87]). Additionally, three biological, and two technical complications required clinical intervention to maintain function, and all occurred in C3. Restorations placed in C1 and C2 showed a significantly reduced risk for failure/intervention (hazard ratio = 0.103, p = 0.026) compared with restorations placed in C3.
LZGC CCPCs showed good five-year clinical performance. However, SVRs and SCRs were significantly influenced by the operator. Additional clinical data are required for a more detailed investigation of this effect.
在一项多中心基于实践的研究中对椅旁制作的锂质氧化锆微晶玻璃(LZGC)部分冠(CCPC)进行临床评估。
在三家私立牙科诊所(C1 - C3)中,71名患者使用92颗粘结固定的CCPC(Cerec SW 4.2/Cerec MC XL/Celtra Duo)进行修复。计算随时间变化的(Kaplan - Meier)生存率(SVR)和成功率(SCR)。在Cox回归模型中评估SVR和SCR的以下可能协变量:修复位置(前磨牙/磨牙)、粘结材料(Variolink/Calibra)和操作者(C1 - C3)。
73颗CCPC放置于59名患者口中并纳入研究(平均观察期:58.0±15个月)。记录到4例完全失败(2例牙齿折断、1例修复体折断和1例牙髓治疗失败)。所有失败和干预均发生在三个中心中的一个(5年SCR:C1 + C2:100%;C3:71%;95%置信区间:[0.55;0.87])。此外,3例生物学并发症和2例技术并发症需要临床干预以维持功能,且均发生在C3。与放置在C3的修复体相比,放置在C1和C2的修复体显示出显著降低的失败/干预风险(风险比 = 0.103,p = 0.026)。
LZGC CCPC显示出良好的五年临床性能。然而,SVR和SCR受操作者显著影响。需要更多临床数据对此效应进行更详细的研究。